{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:47:48Z","timestamp":1790819268151,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2002,5,25]],"date-time":"2002-05-25T00:00:00Z","timestamp":1022284800000},"content-version":"vor","delay-in-days":1454,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1006\/bcmd.1998.0178","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T10:51:07Z","timestamp":1032173467000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Arginine Butyrate-Induced Susceptibility to Ganciclovir in an Epstein\u2013Barr-Virus-Associated Lymphoma"],"prefix":"10.1006","volume":"24","author":[{"given":"Steven J.","family":"Mentzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Fingeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas V.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/bcmd.1998.0178_MD980178RF1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/1097-0142(19941101)74:9<2436::AID-CNCR2820740908>3.0.CO;2-S","article-title":"Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation","volume":"74","author":"Armes","year":"1994","journal-title":"Cancer"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00005792-199103000-00005","article-title":"Epstein-Barr virus lympho-proliferative disease associated with acquired immunodeficiency","volume":"70","author":"Cohen","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1183\/09031936.94.07030612","article-title":"Rapidly growing Epstein-Barr virus-associated pulmonary lymphoma after heart transplantation","volume":"7","author":"Schwend","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198204153061506","article-title":"Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation","volume":"306","author":"Hanto","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/156.2.273","article-title":"Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation","volume":"156","author":"Breinig","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ajcp\/102.3.310","article-title":"Gamma\/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen","volume":"102","author":"Ross","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1349-7006.1994.tb02910.x","article-title":"Epstein-Barr virus-associated post-transplant non-Hodgkin's lymphoma: establishment and characterization of a new cell line","volume":"85","author":"Kawashima","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF8","article-title":"Early detection and treatment of EBV-associated post transplant lymphoproliferative disease","volume":"B-37","author":"Rooney","year":"1993","journal-title":"XVIII Intl. Herpesvirus Workshop Abstract"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-199501150-00024","article-title":"Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis","volume":"59","author":"Kuo","year":"1995","journal-title":"Transplantation"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/thx.50.2.205","article-title":"Necrotic, ulcerative bronchitis, the presenting feature of lymphoproliferative disease following heart-lung transplantation","volume":"50","author":"Egan","year":"1995","journal-title":"Thorax"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(82)90923-8","article-title":"Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry","volume":"73","author":"Purtilo","year":"1982","journal-title":"Am J Med"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1200\/JCO.1987.5.10.1673","article-title":"Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus","volume":"5","author":"List","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ajcp\/101.5.590","article-title":"Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers","volume":"101","author":"Kaplan","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF14","first-page":"201","article-title":"Epstein-Barr virus and human malignancies","volume":"5","author":"Henle","year":"1985","journal-title":"Adv Viral Oncol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1097-0142(19920701)70:1<185::AID-CNCR2820700129>3.0.CO;2-J","article-title":"Epstein-Barr virus integration in human lymphomas and lymphoid cell lines","volume":"70","author":"Gulley","year":"1992","journal-title":"Cancer"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/00000478-199310000-00004","article-title":"Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients","volume":"17","author":"Sabourin","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood.V81.5.1393.1393","article-title":"Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders","volume":"81","author":"Cen","year":"1993","journal-title":"Blood"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00007890-198804000-00011","article-title":"The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children","volume":"45","author":"Ho","year":"1988","journal-title":"Transplantation"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ijc.2910580107","article-title":"Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma","volume":"58","author":"Tao","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V84.3.972.972","article-title":"Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients","volume":"84","author":"Riddler","year":"1994","journal-title":"Blood"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF21","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/1097-0142(19941001)74:7<1959::AID-CNCR2820740722>3.0.CO;2-U","article-title":"Posttrans-plantation plasma cell dyscrasias","volume":"74","author":"Joseph","year":"1994","journal-title":"Cancer"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.1995.tb08905.x","article-title":"Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours","volume":"89","author":"Delecluse","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood.V85.5.1396.bloodjournal8551396","article-title":"Posttrans-plantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus","volume":"85","author":"Frank","year":"1995","journal-title":"Blood"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/5.suppl_2.S29","article-title":"Lymphoma complicating immuno-deficiency disorders","volume":"2","author":"Levine","year":"1994","journal-title":"Ann Oncol 5 Suppl"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V60.1.180.180","article-title":"A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia","volume":"60","author":"Schubach","year":"1982","journal-title":"Blood"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/j.1460-2075.1986.tb04450.x","article-title":"Identification of an Epstein-Barr virus-coded thymidine kinase","volume":"5","author":"Littler","year":"1986","journal-title":"EMBO J"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF27","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1021\/bi00329a034","article-title":"Epstein-Barr virus induces a unique pyrimidine deoxynucleoside kinase activity in superinfected and virus-producer B cell lines","volume":"24","author":"Stinchcombe","year":"1985","journal-title":"Biochemistry"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/jvi.50.1.50-55.1984","article-title":"Prolonged inhibitory effect of 9-(1,3-dihydroxy-2- propoxymethyl)guanine against replication of Epstein-Barr virus","volume":"50","author":"Lin","year":"1984","journal-title":"J Virol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF29","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1128\/jvi.62.10.3892-3895.1988","article-title":"Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems","volume":"62","author":"Littler","year":"1988","journal-title":"J Virol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-107-2-348","article-title":"Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)","volume":"107","author":"Newman","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1988.03720030044031","article-title":"Regression of oral hairy leukoplakia after orally administered acyclovir therapy","volume":"259","author":"Resnick","year":"1988","journal-title":"JAMA"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF32","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/jvi.64.11.5441-5447.1990","article-title":"Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection","volume":"64","author":"Contreras-Salazar","year":"1990","journal-title":"J Virol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3835(81)90066-5","article-title":"Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells","volume":"12","author":"Ito","year":"1981","journal-title":"Cancer Lett"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3835(80)90003-8","article-title":"Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate","volume":"8","author":"Roubal","year":"1980","journal-title":"Cancer Lett"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0042-6822(80)90326-8","article-title":"Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus","volume":"107","author":"Saemundsen","year":"1980","journal-title":"Virology"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01309995","article-title":"Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation","volume":"81","author":"Anisimova","year":"1984","journal-title":"Arch Virol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF37","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/00007890-199606270-00010","article-title":"Immunoblastic lymphoma of donor origin in the allograft after lung transplantation","volume":"61","author":"Mentzer","year":"1996","journal-title":"Transplantation"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF39","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.1074\/jbc.270.23.13637","article-title":"The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding","volume":"270","author":"Weng","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0003-2697(83)90418-9","article-title":"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity","volume":"132","author":"Feinberg","year":"1983","journal-title":"Anal Biochem"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF41","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1016\/S0021-9258(17)33983-2","article-title":"Platelet-derived growth factor (PDGF) induction of egr-1 is independent of PDGF receptor autopho-sphorylation on tyrosine","volume":"269","author":"Mundschau","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/abio.1994.1268","article-title":"Quantitative estimation of the degree of cell spreading on different surfaces and cell monolayers using a fluorescent plate scanner","volume":"219","author":"Ginis","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF43","first-page":"476","article-title":"Phase I clinical trial of arginine butyrate in patients with refractory neoplasms","volume":"14","author":"Sanders","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00062752-199502020-00002","article-title":"Butyrate in the treatment of sickle cell disease and beta-thalassemia","volume":"2","author":"Faller","year":"1995","journal-title":"Curr Opin Hemat"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199301143280202","article-title":"A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders","volume":"328","author":"Perrine","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01989417","article-title":"Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies","volume":"49","author":"Perrine","year":"1993","journal-title":"Experientia"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V74.1.454.454","article-title":"Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia","volume":"74","author":"Perrine","year":"1989","journal-title":"Blood"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation [see comments]","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF49","first-page":"877","article-title":"Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression","volume":"10","author":"Armitage","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF50","series-title":"Immune Deficiency and Cancer","article-title":"Lymphoma in cardiac transplant recipients associated with cyclosporin A, prednisone and anti-thymocyte globulin (ATG)","author":"Bieber","year":"1984"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF51","first-page":"173","article-title":"The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF52","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood.V82.7.2257.2257","article-title":"Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation [letter]","volume":"82","author":"Oettle","year":"1993","journal-title":"Blood"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF53","first-page":"1","article-title":"Epstein-Barr virus associated proliferative disease and neoplasia","volume":"13","author":"Fingeroth","year":"1990","journal-title":"Inf Dis Prac"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF54","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00007890-198903000-00012","article-title":"Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses","volume":"47","author":"Hanto","year":"1989","journal-title":"Transplantation"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF55","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF56","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/jvi.65.2.976-980.1991","article-title":"Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4","volume":"65","author":"Cen","year":"1991","journal-title":"J Virol"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO;2-4","article-title":"Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child","volume":"51","author":"Novogrodsky","year":"1983","journal-title":"Cancer"},{"key":"10.1006\/bcmd.1998.0178_MD980178RF58","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0277-5379(87)90109-X","article-title":"Clinical pharmacology of sodium butyrate in patients with acute leukemia","volume":"23","author":"Miller","year":"1987","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979698901784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979698901784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:18:15Z","timestamp":1761049095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979698901784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["S1079979698901784"],"URL":"https:\/\/doi.org\/10.1006\/bcmd.1998.0178","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[1998,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine Butyrate-Induced Susceptibility to Ganciclovir in an Epstein\u2013Barr-Virus-Associated Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/bcmd.1998.0178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}